Drug Development
Isotopic Labelling in Drug Development
Isotopic labelling continues to be one of the most effective ways of understanding how drug candidates behave once they enter
How GMP-Ready 3D Printers Are Redefining Small-Batch Capsule Filling in Drug Development
From preclinical studies to firstinhuman trials GMPcompliant D printing platforms deliver automated capsule filling
When to Consider Micronisation Early
How Particle Engineering Prevents Costly Bioavailability Failures in Phase I and Beyond
Micronization by spiral jet mill process is the first and the most effective process usually implemented or tested
The Evolution of mRNA Therapeutics
Recent Advances, Challenges, and the Path Forward
Scientists have debated the promise of mRNA as a therapeutic modality for over years Over this period the field has made great
Orchestrating a Commercially Successful Cell and Gene Therapy
The Role of Technology in Operational Scalability
The cell and gene therapy CGT landscape is rapidly evolving offering groundbreaking treatments for previously incurable diseases
Artificial Intelligence in Drug Development
Innovations and Challenges
Although Artificial Intelligence AI took root in the mid twentieth century shortly after the advent of computers
Accelerating the Drug Development Process
The bodys immune system exhibits a remarkable ability to scrutinize a cells interior a function of central importance
Blood to Plasma Ratio: An Important Determinant of the Pharmacokinetic Behavior of Drugs
The bloodtoplasma ratio BP ratio or Rb is an important parameter in pharmacokinetics PK that reflects the distribution of a drug between red blood cells RBCs and plasma
New Pharmacological Targets and Biomarkers for the Treatment of Tuberculosis (TB)
Mycobacterium tuberculosis MTB which has harmed people for more than decades is the cause of the chronic lung infectious disease known as pulmonary tuberculosis TB
Effective Biomarkers in Uncovering Novel Target Molecules for a Drug
The Revolution in New Drug Targets
Biological markers or the more commonly used term Biomarkers was first heard of in the s In the coming years this term gained unprecedented popularity as myriad studies were carried out regarding the efficacy of biomarkers in the drug discovery and development process as well as in the medical diagnosis of diseases
